Severe acute respiratory syndrome coronavirus 2 infection in patients with prostate cancer: A critical review.
Journal Information
Full Title: Crit Rev Oncol Hematol
Abbreviation: Crit Rev Oncol Hematol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declaration of Competing Interest OC received honoraria from Astellas, Astra Zeneca, Bayer, Janssen, Pfizer, was advisor for Astellas, Janssen, MSD, was speaker for Astellas The other authors have no disclosure to make."
Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025